| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,329 |
1,230 |
$66K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,341 |
744 |
$48K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
143 |
104 |
$14K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,447 |
701 |
$8K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
230 |
83 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
115 |
92 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
258 |
80 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
547 |
202 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
261 |
41 |
$882.07 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
82 |
30 |
$450.87 |
| 36415 |
Collection of venous blood by venipuncture |
26 |
26 |
$67.50 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
51 |
14 |
$47.99 |
| 96127 |
|
272 |
38 |
$38.25 |